1、 Zheng Z#, Chen H, Li J, Li T, Zheng B, Zheng Y, Jin H, He Y, Gu Q, Xu X. Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin. Diabetes,2012; 61(1):217-228
2、Chen H,Zheng Z*,Huang Y,Guo K,Lu J,Zhang L,Yu H,Bao Y,Jia W. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLoS One,2012;7(5): e36718
3、Zhao S, Li T, Zheng B, Zheng Z#. Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: A meta-analysis. Ophthalmic Genet,2012;33(4):200-7
4、Jin J, Zhou KK, Park K, Hu Y, Xu X, Zheng Z#, Tyagi P, Kompella UB, Ma JX. Anti-inflammatory and Antiangiogenic Effects of Nanoparticle-Mediated Delivery of a Natural Angiogenic Inhibitor. Invest Ophthalmol Vis Sci,2011;52(9):6230-6237
5、 Zheng B, Li T, Chen H, Xu X, Zheng Z#. Correlation between Ficolin-3 and Vascular Endothelial Growth Factor-to-Pigment Epithelium-Derived Factor Ratio in the Vitreous of Eyes with Proliferative Diabetic Retinopathy. Am J Ophthalmol,2011;152(6):1039-1043
6、Chen HB, Zheng Z*, Li RX, Lu JX, Bao YQ, Ying XF, Zeng R, Jia WP. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy. Am J Nephrol,2010;32(1):47-56
7、Wu H, Xia X, Jiang C, Wu J, Zhang S, Zheng Z, Liu W, Zhang Y, Ren H, Wei C, Xu X. High glucose attenuates insulin-induced VEGF expression in bovine retinal microvascular endothelial cells. Eye,2010;24(1):145-151
8、Zheng Z#, Chen HB, Wang H, Ke BL, Zheng BQ, Li Q, Li PY, Su L, Gu Q, Xu X. Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial ROS pathway mediated by PGC-1α. Diabetes,2010; 59(9): 2315-2325.
9、Zheng Z, Chen HB, Ke GJ, Fan Y, Zou HD, Sun XD, Gu Q, Xu X,Ho PC. The protective effect of perindopril on diabetic retinopathy is associated with decreased VEGF/PEDF ratio: involvement of a mitochondria-ROS pathway. Diabetes,2009;58(4):954-964
10、Chen YH, Xu X, Sheng MJ, Zhang XY, Gu Q, Zheng Z#. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy. Exp Eye Res,2009;89(6):1028-1034
11、Zhao H, Jin H, Li Q, Gu Q, Zheng Z, Wu H, Ye S, Sun X, Xu X, Ho PC. KV11, a small peptide derived from human apolipoprotein(a), inhibits VEGF-induced retinal neovascularization: the safety, penetration, and efficacy. Invest Ophthalmol Vis Sci,2009;50(11):5384-5395
12、Zhu D, Xu X, Zheng Z, Gu Q. Regulation of vascular endothelial growth factor and pigment epithelium-derived factor in rat retinal explants under retinal acidification. Eye,2009;23(11):2105-2111
13、Chen HB, Jia W, Xu X, Fan Y, Zhu D, Wu H, Xie Z, Zheng Z#. Upregulation of PEDF expression by PARP inhibition contributes to the decrease in hyperglycemia-induced apoptosis in HUVECs. Biochem Biophys Res Commun,2008;369(2):718-724
14、Chen YD, Xu X, Xia X, Wu H, Liu K, Zheng Z, Zhu D. MMP9 is involved in glycation end-products induced increase of retinal vascular permeability in rats and the therapeutic effect of minocycline. Curr Eye Res,2008;33(11):977-983
15、Zheng Z, Chen HB, Xu X, Li CX. Effects of angiotensin-converting enzyme inhibitors and β-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy. Exp Eye Res,2007;84(4):745-752
|
